196 related articles for article (PubMed ID: 9703333)
1. Matrix metalloproteinase expression in human retinal microvascular cells.
Grant MB; Caballero S; Tarnuzzer RW; Bass KE; Ljubimov AV; Spoerri PE; Galardy RE
Diabetes; 1998 Aug; 47(8):1311-7. PubMed ID: 9703333
[TBL] [Abstract][Full Text] [Related]
2. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli.
Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F
Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants.
Yao PM; Buhler JM; d'Ortho MP; Lebargy F; Delclaux C; Harf A; Lafuma C
J Biol Chem; 1996 Jun; 271(26):15580-9. PubMed ID: 8663061
[TBL] [Abstract][Full Text] [Related]
4. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
Lafuma C; El Nabout RA; Crechet F; Hovnanian A; Martin M
J Invest Dermatol; 1994 Jun; 102(6):945-50. PubMed ID: 8006459
[TBL] [Abstract][Full Text] [Related]
5. Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio.
Kenney MC; Chwa M; Opbroek AJ; Brown DJ
Cornea; 1994 Mar; 13(2):114-24. PubMed ID: 8156782
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury.
Webb KE; Henney AM; Anglin S; Humphries SE; McEwan JR
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1837-44. PubMed ID: 9327785
[TBL] [Abstract][Full Text] [Related]
7. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
8. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
9. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro.
Nelimarkka LO; Nikkari ST; Ravanti LS; Kähäri VM; Järveläinen HT
Matrix Biol; 1998 Aug; 17(4):293-304. PubMed ID: 9749945
[TBL] [Abstract][Full Text] [Related]
10. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
11. Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes.
Théret N; Musso O; L'Helgoualc'h A; Clément B
Am J Pathol; 1997 Jan; 150(1):51-8. PubMed ID: 9006321
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.
Schaefer L; Han X; August C; Matzkies F; Lorenz T; Schaefer RM
Diabetologia; 1997 Sep; 40(9):1035-43. PubMed ID: 9300240
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
14. Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells.
Frölichsthal-Schoeller P; Vescovi AL; Krekoski CA; Murphy G; Edwards DR; Forsyth P
Neuroreport; 1999 Feb; 10(2):345-51. PubMed ID: 10203333
[TBL] [Abstract][Full Text] [Related]
15. Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture.
Abdel Wahab N; Mason RM
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):777-83. PubMed ID: 9003362
[TBL] [Abstract][Full Text] [Related]
16. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
18. Regulation of collagen degradation in the rat myocardium after infarction.
Cleutjens JP; Kandala JC; Guarda E; Guntaka RV; Weber KT
J Mol Cell Cardiol; 1995 Jun; 27(6):1281-92. PubMed ID: 8531210
[TBL] [Abstract][Full Text] [Related]
19. 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells.
González-Avila G; Iturria C; Vadillo F; Terán L; Selman M; Pérez-Tamayo R
Pathobiology; 1998; 66(1):5-16. PubMed ID: 9577961
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of gelatinases/type IV collagenases in jaw cysts.
Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Hietanen J; Sorsa T
J Oral Pathol Med; 1995 Feb; 24(2):78-84. PubMed ID: 7745546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]